PYX-201 Receives Orphan Drug Designation From the FDA in Pancreatic Cancer
The FDA has granted an orphan drug designation to PYX-201 for the treatment of patients with pancreatic cancer.
Source: onclive.com
Stay updated with breaking news from Yx 201. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has granted an orphan drug designation to PYX-201 for the treatment of patients with pancreatic cancer.